Postuma, Ronald B.
Berg, Daniela
Article History
First Online: 27 October 2016
Competing interests
: R.B.P. has received funding for consultancy from Biotie, Biogen and Roche, and speaker fees from Novartis Canada and Teva Neurosciences. D.B. has received funds for consultancy and/or speaking from Lundbeck, Novartis, Teva and UCB, and research grants from Janssen Pharmaceuticals, Teva and UCB.